Back to CELG-RI

Birchview Capital, LP → CELG-RI

Birchview Capital, LP CELG-RI Position History

Bristol-Myers Squibb Company Ce • Healthcare

Quarters held
5
Latest value
$12K
Q3 2026
Peak value
$18.6M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$16.3M
Q1 2026$18.6M
Q2 2026$17.1M
Q3 2026$14M
Q3 2026$12K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$12K98.5K——
Q3 2026$14M224.2K——
Q2 2026$17.1M297.2K——
Q1 2026$18.6M306.3K——
Q4 2025$16.3M302.8K——

Other funds holding CELG-RI

Other Birchview Capital, LP positions

KLAC

KLA CORPORATION

$53.8M
KLAC

KLA CORPORATION

$32.5M
KLAC

KLA CORPORATION

$29.3M
KLAC

KLA CORPORATION

$26.6M
LRCX

LAM RESEARCH CORPORATION

$15.2M
LRCX

LAM RESEARCH CORPORATION

$9.9M
BDSX

BIODESIX INC

$8.6M
STOK

STOKE THERAPEUTICS INC

$8.3M